CMS Reverses Non-Coverage of Oncology PET Tracers
CMS is allowing local contractors to determine coverage of new oncology PET tracers, but tracers for neurological or cardiac uses aren’t included in the change.
FDA Approves Lymphoseek Imaging Agent
The FDA has approved Lymphoseek (technetium Tc 99m tilmanocept) Injection imaging agent that helps locate lymph nodes in patients with certain cancers.
Amyloid Imaging May Help Detect Cardiac Amyloidosis
Amyloid imaging, used to detect plaques in the brain, may help diagnose cardiac amyloidosis, researchers said.
PET, MRI, Cerebrospinal Analysis Best for Alzheimer’s Test
Combining fluorodeoxyglucose-PET, MRI and cerebrospinal analysis significantly increases the accuracy of predicting Alzheimer’s disease progression.
F-18-FLT PET Assesses Glioma Treatment Progress
F-18-flurorothymidine PET appears to be useful in assessing the grade and proliferation in gliomas, especially in newly diagnosed patients.
Image Wisely Turns to Nuclear Medicine
Dose awareness extends to nuclear medicine exams with the development of online materials to guide providers on radiopharmaceutical dose utilization.
PET Imaging with Amyvid for Alzheimer's
Video: Roberto Soto, MD, discusses using PET imaging with Amyvid for Alzheimer’s evaluation, including reimbursement, training, and benefits of the new test.
By clicking Accept, you agree to become a member of the UBM Medica Community.